Poland· PL-100455330
Onureg
A azacitidine product containing azacitidinum, registered in Poland by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Azacitidine is registered in 18 of 19 countries.
Countries holding a registration under ATC L01BC07 (azacitidine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Azacitidine · ATC L01BC07
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of azacitidine costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.69 in France to $470.17 in Switzerland — a ×683 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Azacitidine · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$470.17
- CZ Czechia$4.72
- FR France$0.69
The record
At a glance
URPL (Poland)- Active substance
- Azacitidinum
- Manufacturer
- Bristol-Myers Squibb Pharma EEIG
- Country
- Poland (PL)
- ATC code
- L01BC07
- ATC class
- Azacitidine
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin07640133688435
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
75 interactions on record for azacitidine.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Azacitidine · interactions on record
75 records
- 30 severe
- 45 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Azacitidine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAZACITIDINE ACCORDAccord Healthcare S.L.U., Barcelona
- NetherlandsAzacitidine Accord 200 mg filmomhulde tablettenAccord Healthcare S.L.U.
- FinlandAzacitidine AccordAccord Healthcare S.L.U.
- United StatesONUREGCelgene Corporation
- SwitzerlandOnureg 200 mg, FilmtablettenBristol-Myers Squibb SA
- SwedenAzacitidine Accord 200 mg Filmdragerad tablettAccord Healthcare S.L.U.
- BelgiumAzacitidine Accord 200 mgAccord Healthcare
- IrelandAzacitidine Accord 200 mg film-coated tabletsAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Azacitidin Hikma, Azacitidin Sandoz
- Belgium · Azacitidin Sandoz, Azacitidine Eugia
- Bulgaria · Азацитидин, Азацитидин Ромфарм
- Cyprus · Azacitidine Koanaa 25 Mg/Ml, Azacitidine Sandoz
- Czechia · Azacitidin Sandoz, Azacitidine Rompharm
- Germany · Azacitidin, Azacitidin Aqvida
- Denmark · Azacitidin "stada Arzneimittel Ag", Azacitidin Adalvo
- Estonia · Azacitidine Auxilia
- Spain · Azacitidina Dr. Reddys, Azacitidina Eugia
- Finland · Azacitidine Hikma, Azacitidine Sandoz
- France · Azacitidine Arrow, Azacitidine Biogaran
- United Kingdom (Northern Ireland) · Azacitidine Amarox, Azacitidine Eugia (Uk)
- Greece · Azacitidine Sandoz, Azacitidine Stada
- Croatia · Azacitidin Pharmascience, Azacitidin Sandoz
- Hungary · Azacitidin Aliud, Azacitidin Sandoz
- Ireland · Azacitdine Clonmel, Azacitidine Clonmel
- Iceland · Azacitidine Accord, Azacitidine Glenmark
- Italy · Azacitidina Aurobindo, Azacitidina Eg Stada
- Liechtenstein · Azacitidine Accord, Azacitidine Kabi
- Lithuania · Azacitidine Auxilia, Azacitidine Icg Farma
- Luxembourg · Azacitidine Azacitidine Eg 25 Mg/Ml Poudre Pour Suspension Injectable, Azacitidine Eurogenerics
- Malta · Azacitidine Adalvo, Azacitidine Lotus
- Netherlands · Azacitidine, Azacitidine Cf
- Norway · Azacitidin Sun, Azacitidin Tillomed
- Portugal · Azacitidina Eugia, Azacitidina Hikma
- Romania · Azacitidină Aqvida, Azacitidină Dr. Reddy’s
- Sweden · Azacitidine Azacitidine Lotus Pharma, Azacitidine Hikma
- Slovenia · Azacitidin Sandoz, Azacitidin Stada
- Slovakia · Azacitidine Glenmark, Azacitidine Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ebe945f7-1a7f-4d00-a42a-8a90f35fd607 GET /v1/drugs/ebe945f7-1a7f-4d00-a42a-8a90f35fd607?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "200 mg",
"packaging": "07640133688435 ¦ Rpz ¦ EU/1/21/1556/001 ¦ 141080\n7 tabl.\nRpz ¦ EU/1/21/1556/002 ¦ 141081\n14 tabl.",
"substance": "Azacitidinum 200 mg",
"common_name": "Azacitidinum",
"pl_product_id": "100455330",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about azacitidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.